Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Keigo Sakanaka et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi et al.|International Journal of Clinical Oncology|2023Cited by 10
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapyYu Imai, Takahiro Kimura, Fumihiko Urabe et al.|International Journal of Clinical Oncology|2023Cited by 7
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective studyFumihiko Urabe, Naoki Uchida, Hirokazu Kagawa et al.|Japanese Journal of Clinical Oncology|2025Cited by 6
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective studyTakahiro Kimura, Naoki Uchida, Fumihiko Urabe et al.|Translational Andrology and Urology|2024Cited by 5